HNRNPC aggravates the symptoms of preeclampsia by regulating m6A-dependent alternative splicing of ACSL3
Inhibiting HNRNPC altered the expression of ferroptosis-related markers and alleviated mouse preeclampsia symptoms, indicating HNRNPC as a potential preeclampsia therapeutic target.
Authors
- Kan Liu (ORCID: https://orcid.org/0000-0001-5633-0023)
- Ranhong Li (ORCID: https://orcid.org/0000-0002-5130-8334)
- Wu Haiying (ORCID: https://orcid.org/0009-0006-1114-6373)
- Li Wang (ORCID: https://orcid.org/0000-0001-7692-5067)
- Tao Tao (ORCID: https://orcid.org/0000-0001-9862-8178)
- Huanping Wang (ORCID: https://orcid.org/0000-0003-4080-3329)
Institutions
- Henan Provincial People's Hospital (CN)
Publication Details
- Journal
- Journal of Hypertension
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1097/hjh.0000000000004168
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00